Recently, the expression of HER2, EGFR1, VEGFR-2, PDGFR-β, c-KIT, and ERK1/ERK2 has been investigated in various canine tumors, with mesenchymal tumors showing the lowest expression levels and carcinomas showing the highest expression levels. Here, MAPK3 is linked to carcinoma.